Clinical Trial

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Recruiting
View on ClinicalTrials.gov →
Summary
A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-11; most recent amendment 2025-06-13.
Status change: Not Yet Recruiting → Recruiting 2024-05-22
Trial Details
NCT Number NCT06305663
Lead Sponsor Bausch & Lomb Incorporated
Conditions Myopia
Enrollment 418 participants
Start Date 2024-03-29
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-15